tetrahydropalmatine has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Lu, D; Wen, H; Wu, Z; Xie, Q; Zhang, Z; Zhu, Y | 1 |
| Li, Y; Wang, W; Wen, H; Zhang, H | 1 |
2 other study(ies) available for tetrahydropalmatine and Lung Injury, Acute
| Article | Year |
|---|---|
Tetrahydropalmatine induces the polarization of M1 macrophages to M2 to relieve limb ischemia-reperfusion-induced lung injury via inhibiting the TLR4/NF-κB/NLRP3 signaling pathway.
Topics: Acute Lung Injury; Animals; Berberine Alkaloids; Inflammation; Lipopolysaccharides; Lung; Macrophages; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Reperfusion; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4 | 2022 |
Tetrahydropalmatine protects against acute lung injury induced by limb ischemia/reperfusion through restoring PI3K/AKT/mTOR-mediated autophagy in rats.
Topics: Acute Lung Injury; Animals; Autophagy; Berberine Alkaloids; Ischemia; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion; TOR Serine-Threonine Kinases | 2020 |